Itacitinib Pre-modulation in DLBCL Receiving CAR T Cell Therapy

Clinical trial NCT05757219 · RECRUITING

Trial details

NCT number: NCT05757219
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Diffuse Large B Cell Lymphoma

Start date: 2023-05-19
Primary completion: 2026-06-20
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.